Product
AZD8630
1 clinical trial
1 indication
Indication
AsthmaClinical trial
Phase I, Randomised, Blinded, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD8630 in Healthy Adult Subjects (Part A) and Adults With Asthma on Medium to High Dose Inhaled Corticosteroids and Long-acting Beta-agonists (Part B)Status: Completed, Estimated PCD: 2023-08-02